ArticleHeliyon2024

ANGPTL3 diminishes the resistance of ovarian cancer to paclitaxel by blocking the PI3K-AKT-mTOR signaling pathway.

Dandan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.